Petco Health & Wellness Company, Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Petco Health & Wellness Company, Inc. (Petco), covering the thirteen and thirty-nine weeks ended November 1, 2025. Petco operates as a single reportable segment, functioning as a pet specialty retailer with an omnichannel ecosystem comprising over 1,500 pet care centers across the U.S., Mexico, and Puerto Rico, alongside digital channels.
Key Financial Metrics
| Metric | 13 Weeks Ended Nov 1, 2025 | 39 Weeks Ended Nov 1, 2025 |
|---|---|---|
| Net Sales | $1.46 billion | $4.45 billion |
| Gross Profit | $569.0 million (38.9% margin) | $1.72 billion (38.8% margin) |
| Operating Income | $29.2 million | $88.6 million |
| Net Income (Attributable to Common Stockholders) | $9.3 million | $11.6 million |
| Adjusted EBITDA | $98.6 million | $301.9 million |
| Free Cash Flow (39 weeks) | N/A | $70.6 million |
| Cash and Cash Equivalents | $237.4 million | $237.4 million |
| Total Debt (First Lien Term Loan) | $1.595 billion | $1.595 billion |
| ABL Revolving Credit Availability | $495.5 million | $495.5 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.1% year-over-year for the quarter and 2.6% for the year-to-date period. This was driven by lower transaction volume, a reduced pet care center count (1,389 vs. 1,413), and a strategic shift toward profitability over volume.
- Comparable Sales: Comparable sales decreased 2.2% for the quarter and 1.6% year-to-date.
- Profitability Improvement: Despite lower sales, the company returned to profitability. Operating income improved significantly from $4.0 million in the prior year quarter to $29.2 million. Net income turned positive at $9.3 million compared to a net loss of $16.7 million in the prior year quarter.
- Margin Expansion: Gross profit margin improved to 38.9% from 38.1% year-over-year due to better inventory management and pricing strategies. SG&A expenses as a percentage of sales decreased to 36.9% from 37.8%.
- Interest Expense: Interest expense decreased 8.3% year-over-year to $32.8 million, primarily due to lower interest rates on the First Lien Term Loan.
Outlook, Risks, and Commentary
- Management Commentary: Management highlighted a disciplined approach to unit costs, pricing, and promotions. Momentum in services (veterinary and grooming) continues to grow, offsetting declines in product sales. The company reduced store count to optimize the footprint.
- Liquidity: Total liquidity stands at $732.9 million, comprising cash on hand and available capacity on the ABL Revolving Credit Facility. Management believes current resources are sufficient for the next 12 months.
- Legislative Impact: The "One Big Beautiful Bill Act" (OBBBA) signed on July 4, 2025, introduced changes to tax legislation (bonus depreciation, R&D expensing), but management noted no material impact on Q3 2025 income taxes.
- Risks: Key risks include macroeconomic pressures (inflation, interest rates, tariffs), increased competition from mass retailers and e-commerce, supply chain constraints, and the ability to execute cost action plans. The company also faces standard risks related to data security and labor laws.
Investor Verification Checklist
- Store Count Reduction: Verify the strategic rationale and long-term impact of closing 24 pet care centers (down to 1,389) on future revenue and operating leverage.
- Comparable Sales Trend: Monitor the 2.2% decline in comparable sales to determine if the shift to a "profitability over volume" strategy is sustainable or if it signals deeper demand issues.
- Debt Service Coverage: Review the $1.595 billion term loan balance against the $98.6 million Adjusted EBITDA to assess debt service capacity, noting the weighted average interest rate of 7.6%.
- Inventory Management: Confirm that the reduction in inventory purchases (reflected in cash flow) aligns with the improved gross margins and does not risk stockouts.
- Non-GAAP Reconciliations: Scrutinize the Adjusted EBITDA reconciliation, specifically the $11.7 million add-back for the Mexico joint venture EBITDA, to understand the quality of earnings.